Forest Laboratories – Latest News on Our Pharmaceutical Business

Welcome to the Forest News Center. Here you will find quick and easy information about our products, research and development, financial reports, and corporate news.

The latest press releases about Forest

08.30.2010 - Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression
07.22.2010 - Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KGaA Settle NAMENDA(R) Patent Litigation
07.20.2010 - Forest Laboratories, Inc. Reports First Quarter FY 2011 EPS of $0.39, Including $0.39 Per Share Charge Related to Settlement in Principle with US Department of Justice and $0.17 Per Share Charge for New Product Licensing Fee

View and Search All Press Releases

For links to press releases, events, and press kits on specific Forest products, view the Media Resources page.